Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation

NCT02942576 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

632

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Edoxaban
DRUG: VKA-Based Regimen
DRUG: VKA-Based Regimen
DRUG: VKA-Based Regimen
DRUG: VKA-Based Regimen

Sponsor

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company